DK0815860T3 - Terfenadincarboxylat og behandlingen af allergiske lidelser - Google Patents

Terfenadincarboxylat og behandlingen af allergiske lidelser

Info

Publication number: DK0815860T3
Authority: DK; Denmark
Prior art keywords: treatment; allergic disorders; compound; formula; terfenadine carboxylate
Prior art date: 1992-08-03

Application number

DK97104837T

Other languages

English (en)

Inventor

James W Young

Raymond L Woosley

Nancy M Gray

Yiwang Chen

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-03

Filing date

1993-08-03

Publication date

2006-08-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27129882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0815860(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-08-03 Application filed by Sepracor Inc filed Critical Sepracor Inc

2006-08-14 Application granted granted Critical

2006-08-14 Publication of DK0815860T3 publication Critical patent/DK0815860T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Epoxy Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK97104837T 1992-08-03 1993-08-03 Terfenadincarboxylat og behandlingen af allergiske lidelser DK0815860T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US92415692A	1992-08-03	1992-08-03
US92418292A	1992-08-03	1992-08-03
EP93918584A EP0701443B2 (en)	1992-08-03	1993-08-03	Terfenadine metabolites and their optically pure isomers for treating allergic disorders

Publications (1)

Publication Number	Publication Date
DK0815860T3 true DK0815860T3 (da)	2006-08-14

Family

ID=27129882

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK97104837T DK0815860T3 (da)	1992-08-03	1993-08-03	Terfenadincarboxylat og behandlingen af allergiske lidelser
DK02006356T DK1214937T3 (da)	1992-08-03	1993-08-03	Terfenadincarboxylat og behandling af hudirritation
DK93918584T DK0701443T4 (da)	1992-08-03	1993-08-03	Terfenadinmetabolitter og deres optisk rene isomerer til behandling af allergiske lidelser

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK02006356T DK1214937T3 (da)	1992-08-03	1993-08-03	Terfenadincarboxylat og behandling af hudirritation
DK93918584T DK0701443T4 (da)	1992-08-03	1993-08-03	Terfenadinmetabolitter og deres optisk rene isomerer til behandling af allergiske lidelser

Country Status (24)

Country	Link
US (1)	US5375693A (da)
EP (4)	EP1214937B1 (da)
JP (6)	JP3041954B2 (da)
KR (1)	KR950702420A (da)
AT (3)	ATE162399T1 (da)
AU (3)	AU675240B2 (da)
BR (1)	BR9306841A (da)
CA (1)	CA2141572C (da)
CZ (1)	CZ27495A3 (da)
DE (5)	DE69334145T2 (da)
DK (3)	DK0815860T3 (da)
ES (3)	ES2284740T3 (da)
FI (1)	FI950467L (da)
GB (1)	GB2284351B (da)
GR (3)	GR960300024T1 (da)
HK (1)	HK1045806B (da)
HU (1)	HU226242B1 (da)
NO (1)	NO310644B1 (da)
PL (1)	PL174373B1 (da)
PT (2)	PT815860E (da)
RO (1)	RO116043B1 (da)
RU (1)	RU2167657C2 (da)
SK (1)	SK12495A3 (da)
WO (1)	WO1994003170A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993023047A1 (en) *	1992-05-11	1993-11-25	Merrell Dow Pharmaceuticals Inc.	Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
KR950702420A (ko) *	1992-08-03	1995-07-29	데이비드 사무소 웰	알레르기 질환 치료를 위한 테르페나딘 대사물과 그것의 광학 순수 이성체(terfenadine metabolites and their optically pure isomers for treating allergic disorders)
EP0723958A1 (en) *	1993-06-24	1996-07-31	Albany Molecular Research, Inc.	Synthesis of substantially pure terfenadine derivatives
US20020007068A1 (en)	1999-07-16	2002-01-17	D'ambra Thomas E.	Piperidine derivatives and process for their production
WO1995010278A1 (en) *	1993-10-15	1995-04-20	Hoechst Marion Roussel, Inc.	Treatment of allergic disorders with terfenadine carboxylate
US20030045722A1 (en) *	1994-05-18	2003-03-06	Henton Daniel R.	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
EP0766668B1 (en) *	1994-05-18	2002-07-17	Aventis Pharmaceuticals Inc.	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
US5455049A (en) *	1995-01-04	1995-10-03	Ascent Pharmaceuticals, Inc.	Terfenadine oral powder
WO1996026726A1 (en) *	1995-02-28	1996-09-06	Hoechst Marion Roussel, Inc.	Pharmaceutical composition for piperidinoalkanol compounds
GB9513972D0 (en) *	1995-07-08	1995-09-06	Merck Sharp & Dohme	Pharmaceutical compositions
US5906747A (en) *	1995-11-13	1999-05-25	Biosepra Inc.	Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US5733756A (en) *	1996-01-05	1998-03-31	Celgene Corporation	Lactams and processes for stereoselective enrichment of lactams, amides, and esters
US6355656B1 (en)	1995-12-04	2002-03-12	Celgene Corporation	Phenidate drug formulations having diminished abuse potential
US5837284A (en) *	1995-12-04	1998-11-17	Mehta; Atul M.	Delivery of multiple doses of medications
US5922736A (en) *	1995-12-04	1999-07-13	Celegene Corporation	Chronic, bolus administration of D-threo methylphenidate
US5908850A (en) *	1995-12-04	1999-06-01	Celgene Corporation	Method of treating attention deficit disorders with d-threo methylphenidate
US6486177B2 (en) *	1995-12-04	2002-11-26	Celgene Corporation	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6153754A (en)	1995-12-21	2000-11-28	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
US6201124B1 (en)	1995-12-21	2001-03-13	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
ES2124167B1 (es) *	1996-06-04	1999-09-16	Espanola Prod Quimicos	Nuevos derivados del bencimidazol con actividad antihistaminica.
US5925761A (en) *	1997-02-04	1999-07-20	Sepracor Inc.	Synthesis of terfenadine and derivatives
US6962997B1 (en) *	1997-05-22	2005-11-08	Celgene Corporation	Process and intermediates for resolving piperidyl acetamide steroisomers
UA60335C2 (uk) *	1997-08-26	2003-10-15	Хехст Маріон Рассел, Інк.	Фармацевтична композиція, яка об'єднує піперидиноалканол з протинабряковим агентом
US6194431B1 (en) *	1998-04-14	2001-02-27	Paul D. Rubin	Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
DE19913862C2 (de) *	1999-03-26	2003-04-10	Forschungszentrum Juelich Gmbh	Verfahren zur biokatalysierten Umsetzung schlecht wasserlöslicher Substanzen
DE10007203A1 (de) *	2000-02-17	2001-08-23	Asta Medica Ag	Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6613907B2 (en)	2000-11-08	2003-09-02	Amr Technology, Inc.	Process for the production of piperidine derivatives with microorganisms
SK13822003A3 (sk) *	2001-04-09	2004-09-08	Teva Pharmaceutical Industries Ltd.	Polymorfné formy chloridu fexofenadínu
US20030021849A1 (en) *	2001-04-09	2003-01-30	Ben-Zion Dolitzky	Polymorphs of fexofenadine hydrochloride
WO2003020274A1 (en) *	2001-08-30	2003-03-13	Aventis Pharmaceuticals Inc.	Treatment of atopic dermatitis
US20040044038A1 (en) *	2002-06-10	2004-03-04	Barnaba Krochmal	Polymorphic form XVI of fexofenadine hydrochloride
US20050026890A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
TW200517114A (en)	2003-10-15	2005-06-01	Combinatorx Inc	Methods and reagents for the treatment of immunoinflammatory disorders
JP4515121B2 (ja)	2004-03-15	2010-07-28	東芝テック株式会社	ワイヤドットプリンタヘッド及びワイヤドットプリンタ
JP4473021B2 (ja)	2004-03-22	2010-06-02	東芝テック株式会社	窒化層形成方法、磁気回路形成部材、アーマチュア、ワイヤドットプリンタヘッド及びワイヤドットプリンタ
US20050239830A1 (en) *	2004-04-26	2005-10-27	Vikram Khetani	Methods of diminishing co-abuse potential
EP1628959A2 (en) *	2004-04-26	2006-03-01	Teva Pharmaceutical Industries Ltd	Crystalline forms of fexofenadine hydrochloride and processes for their preparation
US7498345B2 (en)	2004-09-17	2009-03-03	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
US7498443B2 (en)	2004-09-17	2009-03-03	Albany Molecular Research, Inc.	Process for production of carebastine
JP2008514641A (ja) *	2004-09-28	2008-05-08	テバファーマシューティカルインダストリーズリミティド	結晶形フェキソフェナジン、およびその調製方法
CA2591247A1 (en) *	2004-12-09	2006-06-15	Celgene Corporation	Treatment of patients suffering from a disease having a family history or diagnosis of tics or tourette's syndrome with d-threo methylphenidate
US20070225217A1 (en)	2005-11-09	2007-09-27	Combinatorx, Incorporated	Methods, compositions, and kits for the treatment of medical conditions
NZ608343A (en) *	2007-04-13	2014-09-26	Southern Res Inst	Anti-angiogenic agents and methods of use
US20090076080A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched fexofenadine
US20150238473A1 (en) *	2012-09-27	2015-08-27	University Of Rochester	Methods and compositions for treating infection
EP3973957A1 (en)	2015-03-26	2022-03-30	Sen-Jam Pharmaceutical LLC	Methods and compositions to inhibit symptoms associated with veisalgia
DE102017130361A1 (de)	2017-12-18	2019-07-04	Lsp Innovative Automotive Systems Gmbh	Statorzahn und Stator mit guter elektrischer Isolierung und gleichzeitig sehr hoher Wärmeleitfähigkeit zur Leistungssteigerung von Elektromotoren

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US880801A (en) †		1908-03-03	Harold Larsen	Vibrator.
US922890A (en) †	1907-03-26	1909-05-25	Peder Joergen Hansen	Stream-motor.
US4254129A (en) *	1979-04-10	1981-03-03	Richardson-Merrell Inc.	Piperidine derivatives
US4552899A (en) †	1984-04-09	1985-11-12	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4829064A (en) †	1987-06-08	1989-05-09	Analgesic Associates	Cough/cold mixtures comprising non-sedating antihistamine drugs
US4929605A (en) *	1987-10-07	1990-05-29	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol derivatives
US4996061A (en) †	1987-10-07	1991-02-26	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol-decongestant combination
ES2176201T3 (es) *	1992-04-10	2002-12-01	Merrell Pharma Inc	Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.
WO1993023047A1 (en) *	1992-05-11	1993-11-25	Merrell Dow Pharmaceuticals Inc.	Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
KR950702420A (ko) *	1992-08-03	1995-07-29	데이비드 사무소 웰	알레르기 질환 치료를 위한 테르페나딘 대사물과 그것의 광학 순수 이성체(terfenadine metabolites and their optically pure isomers for treating allergic disorders)
EP0723958A1 (en) *	1993-06-24	1996-07-31	Albany Molecular Research, Inc.	Synthesis of substantially pure terfenadine derivatives
CN1168717C (zh) *	1993-06-25	2004-09-29	默里尔药物公司	用于制备抗组胺哌啶衍生物的新中间体
CA2128821A1 (en) *	1993-07-27	1995-01-28	Dilip J. Gole	Freeze-dried pharmaceutical dosage form and process for separation thereof
CA2128820A1 (en) *	1993-07-27	1995-01-28	Walter G. Gowan, Jr.	Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
WO1995010278A1 (en) *	1993-10-15	1995-04-20	Hoechst Marion Roussel, Inc.	Treatment of allergic disorders with terfenadine carboxylate

1993
- 1993-08-03 KR KR1019950700382A patent/KR950702420A/ko not_active Ceased
- 1993-08-03 EP EP02006356A patent/EP1214937B1/en not_active Revoked
- 1993-08-03 CA CA002141572A patent/CA2141572C/en not_active Expired - Lifetime
- 1993-08-03 DK DK97104837T patent/DK0815860T3/da active
- 1993-08-03 PT PT97104837T patent/PT815860E/pt unknown
- 1993-08-03 WO PCT/US1993/007260 patent/WO1994003170A1/en active IP Right Grant
- 1993-08-03 RO RO95-00160A patent/RO116043B1/ro unknown
- 1993-08-03 DE DE69334145T patent/DE69334145T2/de not_active Expired - Lifetime
- 1993-08-03 ES ES02006356T patent/ES2284740T3/es not_active Expired - Lifetime
- 1993-08-03 DE DE69316660T patent/DE69316660T3/de not_active Expired - Lifetime
- 1993-08-03 DK DK02006356T patent/DK1214937T3/da active
- 1993-08-03 DK DK93918584T patent/DK0701443T4/da active
- 1993-08-03 PT PT02006356T patent/PT1214937E/pt unknown
- 1993-08-03 SK SK124-95A patent/SK12495A3/sk unknown
- 1993-08-03 BR BR9306841A patent/BR9306841A/pt not_active Application Discontinuation
- 1993-08-03 ES ES93918584T patent/ES2086270T5/es not_active Expired - Lifetime
- 1993-08-03 PL PL93307339A patent/PL174373B1/pl unknown
- 1993-08-03 GB GB9502183A patent/GB2284351B/en not_active Revoked
- 1993-08-03 EP EP93918584A patent/EP0701443B2/en not_active Expired - Lifetime
- 1993-08-03 EP EP06114048A patent/EP1688142A1/en not_active Withdrawn
- 1993-08-03 DE DE0701443T patent/DE701443T1/de active Pending
- 1993-08-03 AT AT93918584T patent/ATE162399T1/de active
- 1993-08-03 AU AU47986/93A patent/AU675240B2/en not_active Expired
- 1993-08-03 DE DE9320925U patent/DE9320925U1/de not_active Expired - Lifetime
- 1993-08-03 AT AT02006356T patent/ATE363283T1/de active
- 1993-08-03 ES ES97104837T patent/ES2257757T3/es not_active Expired - Lifetime
- 1993-08-03 AT AT97104837T patent/ATE322899T1/de active
- 1993-08-03 EP EP97104837A patent/EP0815860B1/en not_active Revoked
- 1993-08-03 JP JP6505499A patent/JP3041954B2/ja not_active Expired - Lifetime
- 1993-08-03 DE DE69334008T patent/DE69334008T2/de not_active Expired - Lifetime
- 1993-08-03 HU HU9500313A patent/HU226242B1/hu unknown
- 1993-08-03 RU RU95107881/14A patent/RU2167657C2/ru active
1994
- 1994-02-02 US US08/191,061 patent/US5375693A/en not_active Expired - Lifetime
1995
- 1995-02-01 NO NO19950374A patent/NO310644B1/no not_active IP Right Cessation
- 1995-02-02 FI FI950467A patent/FI950467L/fi unknown
- 1995-02-03 CZ CZ95274A patent/CZ27495A3/cs unknown
1996
- 1996-05-31 GR GR960300024T patent/GR960300024T1/el unknown
- 1996-11-19 AU AU71822/96A patent/AU7182296A/en not_active Abandoned
1998
- 1998-04-03 GR GR980400714T patent/GR3026530T3/el unknown
1999
- 1999-02-25 AU AU18429/99A patent/AU1842999A/en not_active Abandoned
- 1999-10-13 JP JP11291216A patent/JP2000086512A/ja active Pending
- 1999-10-13 JP JP11291230A patent/JP3037697B2/ja not_active Expired - Lifetime
- 1999-10-13 JP JP29122399A patent/JP3288661B2/ja not_active Expired - Lifetime
- 1999-10-13 JP JP29122899A patent/JP3288662B2/ja not_active Expired - Lifetime
- 1999-10-13 JP JP29122099A patent/JP3288660B2/ja not_active Expired - Lifetime
2001
- 2001-02-14 GR GR20010400247T patent/GR3035417T3/el unknown
2002
- 2002-08-17 HK HK02106014.7A patent/HK1045806B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2086270T5 (es)	2001-02-01
EP1688142A1 (en)	2006-08-09
BR9306841A (pt)	1998-12-08
CA2141572A1 (en)	1994-02-17
AU4798693A (en)	1994-03-03
JPH08500348A (ja)	1996-01-16
GR3035417T3 (en)	2001-05-31
PL174373B1 (pl)	1998-07-31
GB2284351A (en)	1995-06-07
FI950467A0 (fi)	1995-02-02
DE9320925U1 (de)	1995-08-31
HU226242B1 (en)	2008-07-28
GR3026530T3 (en)	1998-07-31
AU675240B2 (en)	1997-01-30
AU1842999A (en)	1999-04-29
DE69334008D1 (de)	2006-05-24
GR960300024T1 (en)	1996-05-31
JP2000086512A (ja)	2000-03-28
DE69334145T2 (de)	2008-01-24
EP1214937A2 (en)	2002-06-19
JP2000086516A (ja)	2000-03-28
HK1045806B (zh)	2008-03-14
EP1214937B1 (en)	2007-05-30
NO310644B1 (no)	2001-08-06
KR950702420A (ko)	1995-07-29
PT815860E (pt)	2006-08-31
NO950374L (no)	1995-03-29
EP0815860A3 (en)	1998-01-14
DE69334145D1 (de)	2007-07-12
RO116043B1 (ro)	2000-10-30
DK1214937T3 (da)	2007-09-17
NO950374D0 (no)	1995-02-01
ATE363283T1 (de)	2007-06-15
ES2284740T3 (es)	2007-11-16
DK0701443T3 (da)	1998-02-09
JP3288660B2 (ja)	2002-06-04
EP0815860B1 (en)	2006-04-12
JP3037697B2 (ja)	2000-04-24
JP3288661B2 (ja)	2002-06-04
EP1214937A3 (en)	2002-10-30
US5375693A (en)	1994-12-27
HU9500313D0 (en)	1995-03-28
EP0701443A1 (en)	1996-03-20
DE69334008T2 (de)	2006-10-19
DE69316660T3 (de)	2001-04-05
EP0701443B1 (en)	1998-01-21
SK12495A3 (en)	1997-01-08
DE701443T1 (de)	1997-01-30
ES2257757T3 (es)	2006-08-01
DE69316660T2 (de)	1998-05-07
PT1214937E (pt)	2007-07-25
RU95107881A (ru)	1996-11-27
AU7182296A (en)	1997-01-30
EP0701443B2 (en)	2000-11-22
JP2000086514A (ja)	2000-03-28
GB9502183D0 (en)	1995-03-22
ATE322899T1 (de)	2006-04-15
JP2000086515A (ja)	2000-03-28
WO1994003170A1 (en)	1994-02-17
JP3041954B2 (ja)	2000-05-15
DK0701443T4 (da)	2000-12-18
ATE162399T1 (de)	1998-02-15
CZ27495A3 (en)	1996-09-11
ES2086270T1 (es)	1996-07-01
PL307339A1 (en)	1995-05-15
HK1045806A1 (en)	2002-12-13
CA2141572C (en)	2001-02-06
GB2284351B (en)	1996-11-27
RU2167657C2 (ru)	2001-05-27
JP2000086513A (ja)	2000-03-28
HUT71889A (en)	1996-02-28
ES2086270T3 (es)	1998-03-01
FI950467L (fi)	1995-03-31
JP3288662B2 (ja)	2002-06-04
EP0815860A2 (en)	1998-01-07
DE69316660D1 (de)	1998-02-26

Publication	Publication Date	Title
DK0815860T3 (da)	2006-08-14	Terfenadincarboxylat og behandlingen af allergiske lidelser
ATE158182T1 (de)	1997-10-15	Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
ATE66139T1 (de)	1991-08-15	Kosmetische zusammensetzung.
DE69327328D1 (de)	2000-01-20	Verwendund von norastemizol zur behandlung der allergischen rhinitis
DE60018409D1 (de)	2005-04-07	Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
FR2613617B1 (fr)	1991-09-06	Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine
Naik et al.	1982	8-Methoxypsoralen-lnduced Nail Pigmentation.
RU94020964A (ru)	1996-03-27	Электростатический пластырь "элпласт"